Literature DB >> 2964863

Primary structure of human placental anticoagulant protein.

T Funakoshi1, L E Hendrickson, B A McMullen, K Fujikawa.   

Abstract

The primary structure of human placental anticoagulant protein was determined by a combination of amino acid and nucleotide sequencing techniques. The carboxymethylated protein was digested with cyanogen bromide, and the resulting peptides were separated by gel filtration and high-performance liquid chromatography. A total of 239 out of 319 amino acid residues were identified from 7 cyanogen bromide fragments. A full-length cDNA clone encoding placental anticoagulant protein was isolated from a human placenta cDNA library. This clone was 1.6 kilobases long and contained a translation initiation site coding for methionine, 957 nucleotides encoding for the mature protein, a stop codon, a poly(A) recognition site, and a poly(A) tail. Analysis of the tryptic-blocked peptide that originated from the NH2-terminus of the protein showed that the terminal methionine was removed and the adjacent alanine residue was acetylated by posttranslational events. Placental anticoagulant protein is composed of 319 amino acids with acetylalanine as the NH2-terminus and has a high degree of sequence identity with lipocortins I and II. It contains four internal repeats, each including a sequence corresponding to a putative Ca2+-dependent phospholipid binding site. Placental anticoagulant protein is a member of the lipocortin/calpactin family.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2964863     DOI: 10.1021/bi00399a011

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  20 in total

Review 1.  Proteomic analysis of the presynaptic active zone.

Authors:  W Volknandt; M Karas
Journal:  Exp Brain Res       Date:  2012-02-22       Impact factor: 1.972

2.  Numerical classification of coding sequences.

Authors:  D W Collins; C C Liu; T H Jukes
Journal:  Nucleic Acids Res       Date:  1992-03-25       Impact factor: 16.971

3.  Peripheral protein organization and its influence on lipid diffusion in biomimetic membranes.

Authors:  Kanika Vats; Kristofer Knutson; Anne Hinderliter; Erin D Sheets
Journal:  ACS Chem Biol       Date:  2010-04-16       Impact factor: 5.100

4.  Characterization of cDNA encoding human placental anticoagulant protein (PP4): homology with the lipocortin family.

Authors:  U Grundmann; K J Abel; H Bohn; H Löbermann; F Lottspeich; H Küpper
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

5.  Seventh International Conference on Methods in Protein Sequence Analysis. July 3-8, 1988, West Berlin, F.R.G. Short communications.

Authors: 
Journal:  J Protein Chem       Date:  1988-06

6.  The sub-cellular localization of annexin V in cultured chick-embryo fibroblasts.

Authors:  J J Koster; C M Boustead; C A Middleton; J H Walker
Journal:  Biochem J       Date:  1993-04-15       Impact factor: 3.857

Review 7.  Novel antithrombotic drugs in development.

Authors:  M Verstraete; P Zoldhelyi
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

8.  Phospholipid binding of antiphospholipid antibodies and placental anticoagulant protein.

Authors:  L R Sammaritano; A E Gharavi; C Soberano; R A Levy; M D Lockshin
Journal:  J Clin Immunol       Date:  1992-01       Impact factor: 8.317

9.  Purification of cardiac annexin V from the beagle dog heart and changes in its localization in the ischemic rat heart.

Authors:  N Kaneko; R Matsuda; F Chiwaki; S Hosoda
Journal:  Heart Vessels       Date:  1994       Impact factor: 2.037

10.  Annexin 5 as a potential regulator of annexin 1 phosphorylation by protein kinase C. In vitro inhibition compared with quantitative data on annexin distribution in human endothelial cells.

Authors:  P Raynal; F Hullin; J M Ragab-Thomas; J Fauvel; H Chap
Journal:  Biochem J       Date:  1993-06-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.